scispace - formally typeset
Search or ask a question
Institution

University of Rouen

EducationRouen, France
About: University of Rouen is a education organization based out in Rouen, France. It is known for research contribution in the topics: Population & Receptor. The organization has 7299 authors who have published 13209 publications receiving 313477 citations.
Topics: Population, Receptor, Laser, Atom probe, Membrane


Papers
More filters
Journal ArticleDOI
TL;DR: BMI, but not long-term glucose control, was positively and independently associated with tracheal intubation and/or death within 7 days of admission in people with diabetes hospitalised for COVID-19.
Abstract: Coronavirus disease-2019 (COVID-19) is a life-threatening infection caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus. Diabetes has rapidly emerged as a major comorbidity for COVID-19 severity. However, the phenotypic characteristics of diabetes in COVID-19 patients are unknown. We conducted a nationwide multicentre observational study in people with diabetes hospitalised for COVID-19 in 53 French centres in the period 10–31 March 2020. The primary outcome combined tracheal intubation for mechanical ventilation and/or death within 7 days of admission. Age- and sex-adjusted multivariable logistic regressions were performed to assess the prognostic value of clinical and biological features with the endpoint. ORs are reported for a 1 SD increase after standardisation. The current analysis focused on 1317 participants: 64.9% men, mean age 69.8 ± 13.0 years, median BMI 28.4 (25th–75th percentile: 25.0–32.7) kg/m2; with a predominance of type 2 diabetes (88.5%). Microvascular and macrovascular diabetic complications were found in 46.8% and 40.8% of cases, respectively. The primary outcome was encountered in 29.0% (95% CI 26.6, 31.5) of participants, while 10.6% (9.0, 12.4) died and 18.0% (16.0, 20.2) were discharged on day 7. In univariate analysis, characteristics prior to admission significantly associated with the primary outcome were sex, BMI and previous treatment with renin–angiotensin–aldosterone system (RAAS) blockers, but not age, type of diabetes, HbA1c, diabetic complications or glucose-lowering therapies. In multivariable analyses with covariates prior to admission, only BMI remained positively associated with the primary outcome (OR 1.28 [1.10, 1.47]). On admission, dyspnoea (OR 2.10 [1.31, 3.35]), as well as lymphocyte count (OR 0.67 [0.50, 0.88]), C-reactive protein (OR 1.93 [1.43, 2.59]) and AST (OR 2.23 [1.70, 2.93]) levels were independent predictors of the primary outcome. Finally, age (OR 2.48 [1.74, 3.53]), treated obstructive sleep apnoea (OR 2.80 [1.46, 5.38]), and microvascular (OR 2.14 [1.16, 3.94]) and macrovascular complications (OR 2.54 [1.44, 4.50]) were independently associated with the risk of death on day 7. In people with diabetes hospitalised for COVID-19, BMI, but not long-term glucose control, was positively and independently associated with tracheal intubation and/or death within 7 days. clinicaltrials.gov NCT04324736.

631 citations

Journal ArticleDOI
TL;DR: The potential and limits of plant cells as a factory for the production of mammalian glycoproteins will be illustrated and fast progress is currently made by using N-linked glycan structures as milestones of the intracellular transport of proteins along the plant secretory pathway.
Abstract: N-glycosylation is a major modification of proteins in plant cells. This process starts in the endoplasmic reticulum by the co-translational transfer of a precursor oligosaccharide to specific asparagine residues of the nascent polypeptide chain. Processing of this oligosaccharide into high-mannose-type, paucimannosidic-type, hybrid-type or complex-type N-glycans occurs in the secretory pathway as the glycoprotein moves from the endoplasmic reticulum to its final destination. At the end of their maturation, some plant N-glycans have typical structures that differ from those found in their mammalian counterpart by the absence of sialic acid and the presence of β(1,2)-xylose and α(1,3)-fucose residues. Glycosidases and glycosyltransferases that respectively catalyse the stepwise trimming and addition of sugar residues are generally considered as working in a co-ordinated and highly ordered fashion to form mature N-glycans. On the basis of this assembly line concept, fast progress is currently made by using N-linked glycan structures as milestones of the intracellular transport of proteins along the plant secretory pathway. Further developments of this approach will need to more precisely define the topological distribution of glycosyltransferases within a plant Golgi stack. In contrast with their acknowledged role in the targeting of lysosomal hydrolases in mammalian cells, N-glycans have no specific function in the transport of glycoproteins into the plant vacuole. However, the presence of N-glycans, regardless of their structures, is necessary for an efficient secretion of plant glycoproteins. In the biotechnology field, transgenic plants are rapidly emerging as an important system for the production of recombinant glycoproteins intended for therapeutic purposes, which is a strong motivation to speed up research in plant glycobiology. In this regard, the potential and limits of plant cells as a factory for the production of mammalian glycoproteins will be illustrated.

602 citations

Journal ArticleDOI
01 Jun 1994-Test
TL;DR: An overview of the subject of robust Bayesian analysis is provided, one that is accessible to statisticians outside the field, and recent developments in the area are reviewed.
Abstract: Robust Bayesian analysis is the study of the sensitivity of Bayesian answers to uncertain inputs. This paper seeks to provide an overview of the subject, one that is accessible to statisticians outside the field. Recent developments in the area are also reviewed, though with very uneven emphasis.

587 citations

Journal ArticleDOI
TL;DR: The present review aims to give an overview of the principles of action and applications of plasma technologies in biodecontamination.

582 citations

Journal ArticleDOI
TL;DR: Almost 50% of patients with Crohn's disease who were treated for at least 1 year with infliximab and an antimetabolite agent experienced a relapse within 1 year after discontinuation of inflixIMab, however, patients with a low risk of relapse can be identified using a combination of clinical and biologic markers.

563 citations


Authors

Showing all 7360 results

NameH-indexPapersCitations
Yves Agid14166974441
Alexis Brice13587083466
Mohamed Eddaoudi9432764217
Hervé Tilly8647930321
David Cohen8363537722
Jörg Neugebauer8149130909
Hubert Vaudry8097534350
Michel Baudry8037223890
Richard L. Stevens7926419148
Claudine Berr7529727919
Christian P. Robert7553536864
Thierry Frebourg7130722403
Georges Pelletier6943219018
Michel Vert6933317899
Jean-Charles Schwartz6925215917
Network Information
Related Institutions (5)
University of Paris
174.1K papers, 5M citations

96% related

Pierre-and-Marie-Curie University
56.1K papers, 2.3M citations

95% related

University of Paris-Sud
52.7K papers, 2.1M citations

94% related

Centre national de la recherche scientifique
382.4K papers, 13.6M citations

94% related

Université catholique de Louvain
57.3K papers, 2.1M citations

93% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202316
202298
2021603
2020622
2019563
2018552